RxDoctor Payments Data

Steven Berlin, MD

Gynecology · Towson, MDNPI 1568428522

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,439 of the $5,301 with a category attached, or 83.7%. It is spread thinly across 38 manufacturers, the largest accounting for just 22.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,320 and has fallen 92.7% since, to $97 in 2025.

$5,301in general payments, 2019–2025

Across 245 payments — averaging $21.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • Intuitive Surgical$829
  • AbbVie$713
  • Therapeuticsmd, Inc.$362
  • Astellas Pharma US Inc$247
  • Pfizer$199
  • plus $2K from 32 others

What the payments were for

  • Travel & lodging$82916%
  • Food & beverage$4,43984%
  • Education$331%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,301 in reported general payments places this provider in the 85th percentile of 79 gynecology providers in Maryland.

See all gynecology providers in Maryland

Medicare billing

Part B allowed, 2024
$28,504
Medicare patients
173
Services billed
503

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol40$2,877
Tolterodine Tartrate ErTolterodine Tartrate21$2,550
Ibandronate Sodium31$1,395
ValacyclovirValacyclovir Hcl12$1,133
Solifenacin Succinate12$230
NitrofurantoinNitrofurantoin Macrocrystal14$213

Paid to pharmacies, not to this prescriber.

Other gynecology in Towson

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →